See also this year's filing and all EDGAR filings for this company.
PDF Report 0001411158_2012_Anacor_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | NetIncome node detected by tax heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'} |
Graph
Absolute values for 0001411158, Anacor Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 53,045,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,743,000 |
| 3 | remainder_Assets | 1,001,000 |
| 4 | LiabilitiesCurrent | 21,025,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 10,552,000 |
| 9 | ResearchAndDevelopmentExpense | 56,097,000 |
| 10 | remainder_Expenses | 1,396,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 20,101,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 55,789,000 |
| 1 | Liabilities | 21,025,000 |
| 2 | Expenses | 68,045,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 34,764,000 |
| 5 | NetIncome | -47,944,000 |
| 6 | ComprehensiveNetIncome | -47,944,000 |
| 7 | BaseVar | 82,480,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.725 |
| 9 | EconomicCapitalRatio | 2.08 |
Edgar->Model Mapping
Feature Distribution
